Double-blind, Randomized, Dose Optimization Trial of Three Doses of Tipranavir Boosted With Low Dose Ritonavir (TPV/RTV) in Multiple Antiretroviral Drug-experienced Subjects

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Outcome Measure:

Virologic response after 2 weeks of functional monotherapy

Principal Investigator

Boehringer Ingelheim Study Coordinator

Investigator Role:

Study Chair

Investigator Affiliation:

Boehringer Ingelheim Pharmaceuticals

Authority:

United States: Food and Drug Administration

Study ID:

1182.52

NCT ID:

NCT00275444

Start Date:

March 2002

Completion Date:

August 2003

Related Keywords:

• HIV Infections
• HIV Infections
• Acquired Immunodeficiency Syndrome

Name	Location
Duke University Medical Center	Durham, North Carolina  27710
Ohio State University Medical Center	Columbus, Ohio  43210
University of Louisville	Louisville, Kentucky  40202
Atlanta Va Medical Center	Decatur, Georgia  30033
Washington University	St. Louis, Missouri  63110
David Geffen School of Medicine at UCLA	Los Angeles, California  90095
Wake Forest University Baptist Medical Center	Winston-Salem, North Carolina  27157
Boehringer Ingelheim Investigational Site	Phoenix, Arizona
Boehringer Ingelheim Investigational Site	Fountain Valley, California
Living Hope Clinical Trials, Inc.	Long Beach, California
Vincent Lombardi Cancer Center	Washington, D.C., District of Columbia
Therafirst Medical Center	Fort Lauderdale, Florida
1501 N.W. 9th Ave	Miami, Florida
Boehringer Ingelheim Investigational Site	Orlando, Florida
Hillsborough County Health Dept.	Tampa, Florida
Boehringer Ingelheim Investigational Site	Atlanta, Georgia
Mercer University School of Medicine	Macon, Georgia
CORE Center	Chicago, Illinois
Rush-Presbytarian-St Luke's Medical Center	Chicago, Illinois
HIV Outpatient Program (H.O.P)	New Orleans, Louisiana
John's Hopkins University	Baltimore, Maryland
Boehringer Ingelheim Investigational Site	Boston, Massachusetts
Community Research Initiative of New England	Springfield, Massachusetts
University of Michigan Health System	Ann Arbor, Michigan
Boehringer Ingelheim Investigational Site	Kansas City, Missouri
Boehringer Ingelheim Investigational Site	Las Vegas, Nevada
ID Care	Hillsborough, New Jersey
Boehringer Ingelheim Investigational Site	Santa Fe, New Mexico
Albany Medical College	Albany, New York
University of New York at Stony Brook	Stony Brook, New York
Boehringer Ingelheim Investigational Site	Huntersville, North Carolina
Boehringer Ingelheim Investigational Site	Oklahoma City, Oklahoma
Boehringer Ingelheim Investigational Site	Columbia, South Carolina
Boehringer Ingelheim Investigational Site	Houston, Texas
Boehringer Ingelheim Investigational Site	Annandale, Virginia